1. Loss of CCR5 results in glucose intolerance in diet-induced obese mice. Kennedy A, Webb CD, Hill AA, Gruen ML, Jackson LG, Hasty AH (2013) Am J Physiol Endocrinol Metab 305(7): E897-906
    › Citation · 23941876 (PubMed) · PMC3798705 (PubMed Central)
  2. Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice. Garcia JM, Scherer T, Chen JA, Guillory B, Nassif A, Papusha V, Smiechowska J, Asnicar M, Buettner C, Smith RG (2013) Endocrinology 154(9): 3118-29
    › Citation · 23832960 (PubMed) · PMC3749475 (PubMed Central)
  3. Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium. Li Q, Park K, Li C, Rask-Madsen C, Mima A, Qi W, Mizutani K, Huang P, King GL (2013) Circ Res 113(4): 418-27
    › Citation · 23759514 (PubMed) · PMC3893704 (PubMed Central)
  4. Impact of hematopoietic cyclooxygenase-1 deficiency on obesity-linked adipose tissue inflammation and metabolic disorders in mice. Saraswathi V, Ramnanan CJ, Wilks AW, Desouza CV, Eller AA, Murali G, Ramalingam R, Milne GL, Coate KC, Edgerton DS (2013) Metabolism 62(11): 1673-85
    › Citation · 23987235 (PubMed) · PMC4845736 (PubMed Central)
  5. Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension. Fessel JP, Flynn CR, Robinson LJ, Penner NL, Gladson S, Kang CJ, Wasserman DH, Hemnes AR, West JD (2013) Am J Respir Cell Mol Biol 49(5): 778-87
    › Citation · 23742019 (PubMed) · PMC3931097 (PubMed Central)
  6. Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance. Kang L, Lantier L, Kennedy A, Bonner JS, Mayes WH, Bracy DP, Bookbinder LH, Hasty AH, Thompson CB, Wasserman DH (2013) Diabetes 62(6): 1888-96
    › Citation · 23349492 (PubMed) · PMC3661617 (PubMed Central)
  7. Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis. von Wilamowitz-Moellendorff A, Hunter RW, García-Rocha M, Kang L, López-Soldado I, Lantier L, Patel K, Peggie MW, Martínez-Pons C, Voss M, Calbó J, Cohen PT, Wasserman DH, Guinovart JJ, Sakamoto K (2013) Diabetes 62(12): 4070-82
    › Citation · 23990365 (PubMed) · PMC3837029 (PubMed Central)
  8. FGF19 action in the brain induces insulin-independent glucose lowering. Morton GJ, Matsen ME, Bracy DP, Meek TH, Nguyen HT, Stefanovski D, Bergman RN, Wasserman DH, Schwartz MW (2013) J Clin Invest 123(11): 4799-808
    › Citation · 24084738 (PubMed) · PMC3809800 (PubMed Central)
  9. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N, Tyska MJ, Weaver AM (2013) Cell Rep 5(5): 1159-68
    › Citation · 24290760 (PubMed) · PMC3873329 (PubMed Central)
  10. Evaluation of dermal myelinated nerve fibers in diabetes mellitus. Peltier AC, Myers MI, Artibee KJ, Hamilton AD, Yan Q, Guo J, Shi Y, Wang L, Li J (2013) J Peripher Nerv Syst 18(2): 162-7
    › Citation · 23781963 (PubMed) · PMC3693761 (PubMed Central)